Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Digestives & Intestinal Remedies market in Africa is experiencing significant growth and development in recent years. Customer preferences in the market are shifting towards natural and herbal remedies for digestive issues. Consumers are becoming more health-conscious and are seeking products that are gentle on their digestive systems. As a result, there is a growing demand for products that contain natural ingredients such as herbs, probiotics, and enzymes. This trend is driven by the increasing awareness of the potential side effects of synthetic medications and the desire for more sustainable and eco-friendly options.Another trend in the market is the rising popularity of over-the-counter (OTC) digestive remedies. Consumers are increasingly turning to self-medication for minor digestive issues such as indigestion, heartburn, and bloating. This shift is driven by the convenience and accessibility of OTC products, as well as the desire to avoid costly doctor visits and prescription medications. As a result, there is a growing demand for OTC digestive remedies in Africa.Local special circumstances in the African market play a significant role in the development of the Digestives & Intestinal Remedies market. Limited access to healthcare facilities and a shortage of healthcare professionals in some regions make self-medication a more viable option for consumers. Additionally, traditional medicine and herbal remedies have a long-standing presence in African culture, leading to a preference for natural and alternative treatments for digestive issues.Underlying macroeconomic factors also contribute to the growth of the Digestives & Intestinal Remedies market in Africa. Economic growth and increasing disposable incomes in many African countries have led to a rise in healthcare spending. As consumers have more money to spend on healthcare products, they are more likely to invest in digestive remedies to improve their overall well-being. Furthermore, urbanization and changing lifestyles have led to an increase in sedentary lifestyles and unhealthy eating habits, which in turn has resulted in a higher incidence of digestive issues and a greater demand for remedies.In conclusion, the Digestives & Intestinal Remedies market in Africa is experiencing growth and development due to shifting customer preferences towards natural and herbal remedies, the rising popularity of OTC products, local special circumstances such as limited access to healthcare facilities and a preference for traditional medicine, and underlying macroeconomic factors such as economic growth and changing lifestyles.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights